You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 6, June 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Neoplasms
 •Drug Therapy
 •Drug Therapy, Other
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Alert me on articles by topic

Clinical Research in Cutaneous T-Cell Lymphoma Moving Forward

Wolfram Sterry, MD; Lucie Heinzerling, MD

Arch Dermatol. 2008;144(6):786-787.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The 2 articles in this issue of the Archives on cutaneous T-cell lymphoma (CTCL)1-2 highlight several developments related to clinical research in this field. By introducing the term cutaneous T-cell lymphoma in 1980, Edelson3 helped to bridge the gap in communication between dermatologists, talking of reticulohistiocytoma and mycosis fungoides (MF), and hematooncologists, dealing with non-Hodgkin lymphoma and Hodgkin disease. The initial advantage of this unifying concept later became an obstacle for further progress, since some researchers and clinicians lumped together all CTCLs of the skin into 1 disease entity, missing differences in clinical course and therapeutic responses between, for example, MF and Sézary syndrome. It was with the publication of the European Organization for Research and Treatment of Cancer (EORTC)4 classification of cutaneous lymphomas in 1997 that these differences were broadly acknowledged, finally also by the World Health Organization (WHO) pathology group together with . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED ARTICLES

Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
Gaëlle Quereux, Sonia Marques, Jean-Michel Nguyen, Christophe Bedane, Michel D’incan, Olivier Dereure, Elisabeth Puzenat, Alain Claudy, Ludovic Martin, Pascal Joly, Michele Delaunay, Marie Beylot-Barry, Pierre Vabres, Philippe Celerier, Bruno Sasolas, Florent Grange, Amir Khammari, and Brigitte Dreno
Arch Dermatol. 2008;144(6):727-733.
ABSTRACT | FULL TEXT  

Folliculotropic Mycosis Fungoides: An Aggressive Variant of Cutaneous T-Cell Lymphoma
Pedram Gerami, Steve Rosen, Timothy Kuzel, Susan L. Boone, and Joan Guitart
Arch Dermatol. 2008;144(6):738-746.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.